申请人:NOVO NORDISK A/S
公开号:EP2377856A1
公开(公告)日:2011-10-19
The invention provides a compound of general formula (1)
wherein the substituents are defined futher in the application, as well as further embodiments hereof described in the attached embodiments.
The present invention also provides use of the compounds of the invention for preparation of a medicament for the treatment of various diseases, e.g. for the treatment of type 2 diabetes.
本发明提供了通式(1)的化合物
其中取代基在本申请中进一步定义,以及在所附实施例中描述的本发明的进一步实施例。
本发明还提供了本发明化合物用于制备治疗各种疾病的药物的用途,例如用于治疗 2 型糖尿病。